Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Johnson and Johnson
Teva
AstraZeneca
McKesson
Moodys
McKinsey
Federal Trade Commission
Colorcon

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,320,862

« Back to Dashboard

Summary for Patent: 9,320,862
Title:Fluid dispensing device
Abstract: A fluid dispensing device for dispensing a fluid form medicament formulation having a viscosity of from 10 to 2000 mPas, is disclosed having a housing and a fluid discharge device. The fluid discharge device is arranged to be actuated by one or more levers, so as to apply a force to the fluid discharge device which is used to move a container forming part of the fluid discharge device, along a longitudinal axis of the fluid discharge device to cause actuation of a pump forming. A pre-load mechanism prevents actuation of the pump until a pre-determined force is applied to each lever of sufficient magnitude to guarantee the production of a well-developed, efficient spray from the fluid dispensing device.
Inventor(s): Davies; Michael Birsha (Hertfordshire, GB), Hedley; Mark Graham (Hertfordshire, GB), Godfrey; James William (Hertfordshire, GB)
Assignee: Glaxo Group Limited (Brentford, Middlesex, GB)
Application Number:14/303,773
Patent Claim Types:
see list of patent claims
Use; Formulation; Device;

Drugs Protected by US Patent 9,320,862

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Glaxosmithkline Cons FLONASE SENSIMIST ALLERGY RELIEF fluticasone furoate SPRAY, METERED;NASAL 022051-002 Aug 2, 2016 OTC Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 9,320,862

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0325629.4Nov 3, 2003
United Kingdom0405477.1Mar 11, 2004
United Kingdom0420539.9Sep 17, 2004

Non-Orange Book US Patents Family Members for Patent 9,320,862

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,147,461 Fluid dispensing device ➤ Try a Free Trial
8,752,543 Fluid dispensing device ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 9,320,862

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 534589 ➤ Try a Free Trial
Australia 2004287261 ➤ Try a Free Trial
Australia 2005221876 ➤ Try a Free Trial
Australia 2010201953 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Queensland Health
US Army
QuintilesIMS
Healthtrust
Fish and Richardson
Johnson and Johnson
Federal Trade Commission
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.